Tag: global gene delivery technologies size

Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

What Growth Rate Can Be Expected in the Gene Delivery Technologies Market from 2024 Through 2033?

Recent years have seen a swift expansion in the market size of gene delivery technologies. The market is projected to rise from $3.57 billion in 2023 to $4.11 billion in 2024, reflecting a compound annual growth rate (CAGR) of 15.2%. This growth in the historic period can be ascribed to improved comprehension of genetic diseases, progress in cell therapy, the development of nanotechnology, increased gene therapy trials, and elevation in research funding.

The market for gene delivery technologies is predicted to experience a substantial increase in the coming years. The anticipated market value is set to reach $6.96 billion in 2028, with a compound annual growth rate (CAGR) of 14.1%. This growth in the future can be credited to the advancements in precision medicine, improvements in the regulatory framework, the rise of gene therapy, and the broadening scope of non-viral delivery systems. In this forecast period, we can expect to see significant trends such as the use in treating rare diseases, an upswing in clinical trials, precise drug delivery, burgeoning cell therapy, and progress in gene editing tools.

Claim Your Free Sample of the Global Gene Delivery Technologies Market Report Today!

https://www.thebusinessresearchcompany.com/sample.aspx?id=10706&type=smp

What Dynamics Are Shaping the Growth of the gene delivery technologies Market?

The growth of the gene delivery technologies market is anticipated to be fuelled by the rising number of cell and gene therapies. These therapies denote medical procedures aiming to heal or mitigate illnesses by modifying the genetic and cellular composition of a patient’s body. The increase in cell and gene therapies is majorly attributed to the improvements in gene editing technologies that significantly contribute to the creation and commercialization of these therapies. For instance, in October 2022, an article by Economist Impact, a UK-situated corporation that facilitates businesses, governments, and foundations to instigate change and promote progress, stated that approximately 2,600 clinical trials for CGTs were happening in mid-2021. Over half of these have been carried out since 2015 and have surged due to research requirements in various areas. It is predicted that by 2031, the US will have 100 approved CGTs. Plus, the FDA is projected to authorize an average of 8 or 9 CGTs annually between 2022 and 2031. Consequently, the escalation in cell and gene therapies is propelling the gene delivery technologies market.

What Are the Essential Segments of the Gene Delivery Technologies Market?

1) By Mode: Biological, Chemical, Physical

2) By Method: Ex Vivo, In Vivo, In Vitro

3) By Application: Gene Therapy, Cell Therapy, Vaccines, Research

What Are the Defining Trends in the Evolving Gene Delivery Technologies Market?

The increasing adoption of technology is a notable trend gaining traction in the gene delivery technologies market. The primary players in the market are focusing on developing technologically superior products to reinforce their market standing. For example, in February 2023, Aera Therapeutics, a biotechnology firm from the US, unveiled the Aera’s Platform delivery technology aimed at harnessing the power of genetic medicines. The PNP technology of Aera enables the accuracy in targeting RNA molecules implicated in disease development. This technology facilitates targeted gene editing in patient’s cells, paving the way for bespoke gene therapies.

Order Now for Fast Delivery of Your Gene Delivery Technologies Market Report!

https://www.thebusinessresearchcompany.com/report/gene-delivery-technologies-global-market-report

Which Regions Are Emerging as Leaders in the Gene Delivery Technologies Market?

North America was the largest region in the gene delivery technologies market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global gene delivery technologies market report during the forecast period. The regions covered in the gene delivery technologies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The Gene Delivery Technologies Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the gene delivery technologies market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Gene Delivery Technologies Market Include

1. Gene Delivery Technologies Market Executive Summary

2. Gene Delivery Technologies Market Segments

3. Gene Delivery Technologies Market Size And Template Market Growth Rate

4. Key Gene Delivery Technologies Market Trends

5. Major Gene Delivery Technologies Market Drivers

……

25. Key Mergers And Acquisitions In The Gene Delivery Technologies Market

26. Top Gene Delivery Technologies Companies

27. Gene Delivery Technologies Market Opportunities And Strategies

28. Gene Delivery Technologies Market, Conclusions And Recommendations

29. Appendix

Discover Related Reports by The Business Research Company:

Branded Generics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/branded-generics-global-market-report

Specialty Generics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/specialty-generics-global-market-report

Generic Pharmaceuticals Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/generic-pharmaceuticals-global-market-report

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

According to The Business Research Company’s Gene Delivery Technologies Global Market Report 2024, the gene delivery technologies market is expected to show promising growth in the forecast period.

The gene delivery technologies market has experienced rapid expansion in recent years, with significant growth projected for the near future. From enhanced understanding of genetic diseases to the evolution of nanotechnology, several factors have contributed to this upward trajectory.

Current Market Dynamics

• The gene delivery technologies market is set to increase from $3.57 billion in 2023 to $4.11 billion in 2024, boasting a compound annual growth rate (CAGR) of 15.2%.
• This growth is fueled by advancements in cell therapy, the evolution of nanotechnology, and the growth of gene therapy trials.

Future Growth Projections

• Forecasts suggest that the market will reach $6.96 billion by 2028, with a CAGR of 14.1%.
• The proliferation of gene therapy, expansion of non-viral delivery systems, and precision medicine development are key drivers of this anticipated growth.

Surge In Gene And Cell Therapies Drives Momentum

The rise in cell and gene therapies is expected to be a primary catalyst for market growth.

• Advancements in gene editing technologies have paved the way for the development and commercialization of these therapies.
• With thousands of clinical trials underway and an estimated 100 approved cell and gene therapies in the United States by 2031, the momentum is unmistakable.

View More On The Gene Delivery Technologies Market Report 2024 – https://www.thebusinessresearchcompany.com/report/gene-delivery-technologies-global-market-report

Technological Advancements Fuel Market Expansion

Technological innovation emerges as a crucial trend shaping the gene delivery technologies market.

• Aera Therapeutics’ Platform delivery technology, launched in February 2023, exemplifies cutting-edge advancements in the field.
• This technology allows for precise targeting of RNA molecules involved in disease processes, opening doors to personalized gene therapies.

Strategic Acquisitions Bolster Industry Expertise

Strategic acquisitions play a pivotal role in fortifying companies’ positions in the gene delivery technologies market.

• PerkinElmer’s acquisition of SIRION Biotech in June 2021 underscores the importance of gene therapy and viral vector technologies.
• This move strengthens PerkinElmer’s capabilities and positions it as a leading provider of gene delivery technologies.

Market Segmentation

The gene delivery technologies market is segmented across various dimensions:

1. By Mode: Biological, Chemical, Physical.
2. By Method: Ex Vivo, In Vivo, In Vitro.
3. By Application: Gene Therapy, Cell Therapy, Vaccines, Research.

Regional Dynamics

• North America emerged as the largest region in the gene delivery technologies market in 2023.
• However, the Asia-Pacific region is anticipated to experience the fastest growth during the forecast period.

Conclusion

The gene delivery technologies market is witnessing a period of unprecedented growth, fueled by advancements in gene editing, cell therapy, and precision medicine. With technological innovations driving the development of cutting-edge platforms, the landscape of gene delivery is rapidly evolving. Strategic acquisitions further underscore the industry’s dynamism, positioning key players for sustained success. As the market continues to expand, fueled by a surge in gene and cell therapies, stakeholders across the globe stand to benefit from transformative solutions in healthcare and beyond.

Request A Sample Of The Global Gene Delivery Technologies Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=10706&type=smp